DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/5z92zm/pointofdelivery)
has announced the addition of the "Point-of-Delivery
Drug, Reconstitution Systems Markets, Strategies and Prospects"
report to their offering.
Growth in the number of injectable drugs supplied in solid form for
reconstitution prior to administration is being driven by the increase
in drugs based on biological NCEs. These drugs are typically unstable at
ambient temperatures and to preserve their shelf life must be either
stored at low temperature (the so-call 'cold chain') or processed into a
form that will preserve their pharmacological efficacy until they reach
their therapeutic destination.
Because the cost of transporting and storing drugs using refrigeration
is expensive and requires constant temperature monitoring to insure that
the drug has not been exposed to environmental conditions that render
unsafe for use as a therapeutic product, technologies such as
lyophilization are becoming more prevalent.
The packaging and technologies developed and marketed for safe and
reliable reconstitution at the point of administration are benefiting
from this market trend. This report examines commercial drug
reconstitution devices and systems and their impact on the injectable
drug delivery sector.
Highlights
- Analyzes therapeutic demand drivers and evaluates the market impact
and potential of commercial drug reconstitution systems
- Provides analysis of injectable drugs for reconstitution and assesses
key market segments, market dynamics and market demographics
- Forecasts Injectable drug product demand by indication and therapy to
2017
-Profiles reconstitution system suppliers, their product activities,
business strategies, and corporate alliances and affiliations
Topics Covered
Executive Summary
Market Dynamics
Prolonging the Shelf Life of Biological Drugs
Distribution Strategies
Formulation Strategies
Lyophilization and Reconstitution at the Point of Use
Healthcare Economics and Reconstitution Systems
What's Driving the Growth in Engineered Reconstitution Systems?
Biological Drugs Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors
Drug Reconstitution Systems - Commercial Devices
Vial Adapters
Vial-to-Vial Systems
Needle-less Transfer Devices
Direct Connect to Vial
Direct Connect to Cartridge
Dual Chamber Syringes
Dual Chamber Cartridges
Closed Drug Transfer
Reconstitution System Design Factors
Stability and Material Selection Issues
Disposable Drug Cartridges
Single vs Multi-Dose Devices
Human Engineering/Ergonomics
Drug Reconstitution - Therapeutic Sector Analysis
Market Factors
Drug Reconstitution Systems - Company Profiles
For more information visit http://www.researchandmarkets.com/research/5z92zm/pointofdelivery.
